The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts. The compounds are described by the following formula: ##STR1##
Imidazolium salts, intermediates thereto and their use
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0131302A2
公开(公告)日:1985-01-16
The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.